# Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients

> **NCT05255445** · — · COMPLETED · sponsor: **Westat** · enrollment: 157 (actual)

## Conditions studied

- Sickle Cell Disease
- Thalassemia
- Pediatric Cancer

## Interventions

- **BIOLOGICAL:** Red Blood Cell (RBC) Transfusion

## Key facts

- **NCT ID:** NCT05255445
- **Lead sponsor:** Westat
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-16
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-03-31
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2024-05-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05255445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05255445, "Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT05255445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*